BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20363256)

  • 1. Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells.
    Spies CM; Gaber T; Hahne M; Naumann L; Tripmacher R; Schellmann S; Stahn C; Burmester GR; Radbruch A; Buttgereit F
    Immunol Lett; 2010 Jun; 131(1):24-32. PubMed ID: 20363256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
    Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
    J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes.
    Baus E; Andris F; Dubois PM; Urbain J; Leo O
    J Immunol; 1996 Jun; 156(12):4555-61. PubMed ID: 8648096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
    Tenorio EP; Saavedra R
    Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch1 co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production.
    Benson RA; Adamson K; Corsin-Jimenez M; Marley JV; Wahl KA; Lamb JR; Howie SE
    Eur J Immunol; 2005 Mar; 35(3):859-69. PubMed ID: 15688350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
    Crome SQ; Wang AY; Kang CY; Levings MK
    Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic and synergistic effects of glucocorticoids and IL-7 on CD4+ T cell activation.
    Cima I; Fuhrer A; Brunner T
    Immunol Lett; 2006 Jul; 106(1):99-102. PubMed ID: 16723155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses.
    Jirapongsananuruk O; Melamed I; Leung DY
    J Allergy Clin Immunol; 2000 Nov; 106(5):981-5. PubMed ID: 11080724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor.
    Paliogianni F; Ahuja SS; Balow JP; Balow JE; Boumpas DT
    J Immunol; 1993 Oct; 151(8):4081-9. PubMed ID: 8409387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rottlerin inhibits human T cell responses.
    Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O
    Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation-induced cell death signalling in CD4+ T cells by staphylococcal enterotoxin A.
    Porichis F; Morou A; Baritaki S; Spandidos DA; Krambovitis E
    Toxicol Lett; 2008 Jan; 176(1):77-84. PubMed ID: 18054450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
    Lin SJ; Cheng PJ; Hsiao SS
    Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma.
    Vasavda N; Eichholtz T; Takahashi A; Affleck K; Matthews JG; Barnes PJ; Adcock IM
    J Allergy Clin Immunol; 2006 Nov; 118(5):1090-6. PubMed ID: 17088134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10.
    Hertenstein A; Schumacher T; Litzenburger U; Opitz CA; Falk CS; Serafini T; Wick W; Platten M
    Biochem Pharmacol; 2011 Sep; 82(6):632-41. PubMed ID: 21703247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
    Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
    J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.